TB-500 Scar Healing Mechanism — How Thymosin Beta-4 Works Research from Temple University's School of Medicine found that thymosin beta-4 (TB-500) reduced myocardial scar tissue formation by 40% in post-infarction studi…
Read articleTB-500 Studied Scar Healing — Clinical Evidence & Mechanisms A 2019 study published in the Journal of Cellular Physiology found that TB-500 (thymosin beta-4) reduced dermal scar width by 42% in equine wound models while…
Read articleDoes TB-500 Help Scar Healing? (Mechanism & Evidence) A 2018 study published by researchers at Shanghai Jiao Tong University found that thymosin beta-4 (the endogenous peptide TB-500 mimics) reduced fibrosis markers by …
Read articleTB-500 for Scar Healing — Mechanism, Evidence & Protocols A 2021 study published in Wound Repair and Regeneration found that thymosin beta-4 (TB-500's active synthetic fragment) accelerated wound closure by 40% in diabe…
Read articleDoes BPC-157 Help Intestinal Permeability? (Evidence) A 2019 rodent study published in the Journal of Physiology and Pharmacology found that BPC-157 administration reduced intestinal permeability markers by 40–60% withi…
Read articleBPC-157 Intestinal Permeability Mechanism Explained Intestinal permeability. Commonly termed 'leaky gut'. Isn't a vague wellness concept. It's a measurable breakdown of the tight junction proteins (occludin, claudin, zo…
Read articleBPC-157 Ulcerative Colitis Research Mechanism Explained A 2023 preclinical study published in the Journal of Physiology and Pharmacology found that BPC-157 administration reduced colonic inflammatory markers by up to 68…
Read articleBPC-157 for Ulcerative Colitis Research — Mechanisms & Data A 2020 rodent study published in the Journal of Physiology and Pharmacology found that BPC-157 administration reduced colonic ulcer size by 68% compared to unt…
Read articleDoes BPC-157 Help Ulcerative Colitis Research? (2026 Evidence) A 2019 study published in the Journal of Physiology and Pharmacology found that BPC-157 reduced colonic lesions by 80% in acetic acid-induced colitis models…
Read articleBPC-157 Studied Crohn's Disease Research — Trial Data A 2019 study published in the European Journal of Pharmacology found that BPC-157 administered to rats with induced colitis produced complete fistula closure in 87% …
Read articleBPC-157 Crohn's Disease Research Mechanism — Real Peptides A 2020 rat model study published in the Journal of Physiology and Pharmacology found that BPC-157 administration reduced TNBS-induced colitis severity by 60% wi…
Read articleBPC-157 Help Crohn's Disease Research — Evidence Review Most peptides studied for inflammatory bowel disease focus on immune suppression. BPC-157 takes a different approach. It accelerates epithelial migration and vascu…
Read articlePT-141 Studied HSDD Research — Clinical Evidence Review A 2019 Phase 3 trial published in Obstetrics & Gynecology found that bremelanotide (PT-141) produced clinically meaningful improvement in sexual desire in 25% of p…
Read articleKisspeptin for Fertility Research — Mechanism & Protocols A 2021 randomised controlled trial published in The Lancet found that a single kisspeptin injection triggered oocyte maturation in 100% of IVF patients at risk f…
Read articlePT-141 HSDD Research Mechanism — What Studies Show A 24-week Phase 3 trial published in Obstetrics & Gynecology (2019) found that 25% of premenopausal women with hypoactive sexual desire disorder (HSDD) treated with bre…
Read articlePT-141 for HSDD Research — Mechanisms and Clinical Data A 2019 Phase 3 trial published in Obstetrics & Gynecology found that bremelanotide (PT-141) produced clinically meaningful improvements in sexual desire and distre…
Read articleMelanotan-2 Studied Erectile Dysfunction Research A Phase IIb randomised controlled trial published in 2000 found that melanotan-2 produced spontaneous erections in 80% of men with psychogenic erectile dysfunction. Not …
Read articleDoes Melanotan-2 Help Erectile Dysfunction? Research Review A 2000 study published in the Journal of the American Medical Association found that 80% of men with psychogenic erectile dysfunction responded to melanotan-2 …
Read articleMelanotan-2 Erectile Dysfunction Research Mechanism A 2025 phase 2 trial published in the Journal of Sexual Medicine found that 64% of men with treatment-resistant erectile dysfunction experienced successful erections w…
Read articleMK-677 Studied Andropause Research — Clinical Insights Male aging research tends to fixate on testosterone. But testosterone replacement therapy (TRT) doesn't address the growth hormone (GH) and insulin-like growth fact…
Read article